Winkelmayer WC, Chang TI. In Reply to: "Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation" and "Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation". Am J Kidney Dis 2026 Apr 10:S0272-6386(26)00840.
PMID: 41966247